Clinical Trial Update: Cholinergic Nicotinic Receptors and Cognition in PD

View source ↗

Summary

This update reports on a completed clinical trial investigating the role of cholinergic nicotinic receptors in cognitive function in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Michigan | Conditions: Parkinson's Disease | Status: COMPLETED